Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.dovepress.com/review-of-tolerability-of-fremanezumab-for-episodic-and-chronic-migrai-peer-reviewed-fulltext-article-NDT
0
0
Fremanezumab: tolerable ally for treating chronic migraines? | NDT - Dove Medical Press
2/20/23 at 8:01am
Organization
Dovepress.com
Author
Dove Press
Details
32 words
Summarize
Health
Dove Medical Press
Fremanezumab
NDT
Summarizing the history of fremanezumab development, the trials that led to its approval, & the later studies published evaluating its tolerability & efficacy.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...